VASCULAR OCCLUSION side effect
What is VASCULAR OCCLUSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
VASCULAR OCCLUSION and Recently Reported Side Effects
VASCULAR OCCLUSION and 15 most Active Side Effect polls
VASCULAR OCCLUSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with VASCULAR OCCLUSION
ACTIMAX BEXTRA CAPECITABINE CETUXIMAB CHANTIX FABRAZYME FORTEO HUMULIN XALATAN ZELNORMForteo Side Effects Report #5677518-7
Physician from UNITED STATES reported FORTEO problem on Mar 12, 2008. Female patient, 85 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: vascular occlusion, . FORTEO dosage: unknown. Patient recovered.
Chantix Side Effects Report #5394798-6
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Female patient, weighting 164.9 lb, was diagnosed with migraine and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: nausea, vascular occlusion, vomiting, . CHANTIX dosage: unknown. During the same period patient was treated with TOPAMAX, PLAVIX, LIPITOR, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Chantix Side Effects Report #5394798-6
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on July 11, 2007. Female patient, weighting 164.9 lb, was diagnosed with migraine and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: nausea, vascular occlusion, vomiting, . CHANTIX dosage: unknown. During the same period patient was treated with TOPAMAX, PLAVIX, LIPITOR, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Xalatan Side Effects Report #5342493-1
XALATAN problem was reported by a Physician from UNITED KINGDOM on May 21, 2007. Male patient, 78 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vascular occlusion, venous stasis retinopathy, visual acuity reduced, vitreous detachment, . XALATAN dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient recovered.
Actimax Side Effects Report #5285898-X
Physician from GERMANY reported ACTIMAX problem on Mar 29, 2007. Male patient, 70 years of age, was diagnosed with sinobronchitis and was treated with ACTIMAX. After drug was administered, patient experienced the following problems/side effects: cardiac failure, vascular occlusion, . ACTIMAX dosage: unknown. During the same period patient was treated with ROXITHROMYCIN, METOPROLOL SUCCINATE, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.
Bextra Side Effects Report #5312909-5
BEXTRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 26, 2007. Male patient, weighting 224.0 lb, was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, vascular occlusion, . BEXTRA dosage: unknown. Patient was hospitalized. Patient recovered.
Humulin Side Effects Report #5633532-9
Consumer or non-health professional from TURKEY reported HUMULIN R problem on Feb 07, 2008. Female patient, 75 years of age, was treated with HUMULIN R. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, cerebrovascular disorder, vascular occlusion, . HUMULIN R dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5601560-5
CAPECITABINE problem was reported by a Physician from CANADA on Jan 14, 2008. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery occlusion, vascular occlusion, vomiting, . CAPECITABINE dosage: 2150 MG GIVEN TWICE DAILY FOR FOURTEEN DAYS.. During the same period patient was treated with EPIRUBICIN, CARBOPLATIN, METOCLOPRAMIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5578064-1
Physician from CANADA reported CAPECITABINE problem on Dec 18, 2007. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery occlusion, vascular occlusion, vomiting, . CAPECITABINE dosage: 2150 MG GIVEN TWICE DAILY FOR FOURTEEN DAYS.. During the same period patient was treated with EPIRUBICIN, CARBOPLATIN, METOCLOPRAMIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Zelnorm Side Effects Report #5427151-7
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Female patient, 63 years of age, weighting 186.0 lb, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: fatigue, vascular graft, vascular occlusion, . ZELNORM dosage: 3MG BID. During the same period patient was treated with TRICOR, PROTONIX, LASIX, COREG, UNIVASC, ZETIA, NOVOLOG, ASPIRIN. Patient was hospitalized. Patient recovered.
Zelnorm Side Effects Report #5427474-1
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on Aug 20, 2007. Female patient, 63 years of age, weighting 186.0 lb, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: fatigue, vascular graft, vascular occlusion, . ZELNORM dosage: 3MG BID. During the same period patient was treated with TRICOR, PROTONIX, LASIX, COREG, UNIVASC, ZETIA, NOVOLOG, ASPIRIN. Patient was hospitalized. Patient recovered.
Zelnorm Side Effects Report #5345242-6
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, 63 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: fatigue, vascular bypass graft, vascular occlusion, . ZELNORM dosage: unknown. During the same period patient was treated with TRICOR, PROTONIX, LASIX, COREG, UNIVASC, ZETIA. Patient recovered.
Actimax Side Effects Report #5313413-0
Physician from GERMANY reported ACTIMAX problem on Apr 24, 2007. Male patient, 70 years of age, was diagnosed with sinobronchitis and was treated with ACTIMAX. After drug was administered, patient experienced the following problems/side effects: cardiac failure, pulmonary oedema, vascular occlusion, . ACTIMAX dosage: unknown. During the same period patient was treated with ROXITHROMYCIN, METOPROLOL SUCCINATE, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5314640-9
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: angiopathy, myocardial infarction, vascular occlusion, . FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5267017-9
Physician from UNITED STATES reported FABRAZYME problem on Mar 01, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, myocardial infarction, vascular occlusion, . FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5276076-9
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient, 57 years of age, weighting 138.9 lb, was diagnosed with squamous cell carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: lobar pneumonia, multi-organ failure, vascular occlusion, . CETUXIMAB dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 05/11/2006.